VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and Fina Biosolutions LLC (FinaBio), experts in conjugate vaccine development and conjugate chemistry, today announced the signing of a joint IP and licensing agreement.

Journals that published Richard Lynn’s racist ‘research’ articles should retract them

In 2012, the Elsevier journal Personality and Individual Differences published a special issue that included articles with titles like “Life history theory and race differences:

June 20, 2024

High Levels of Radon Exposure: Risk Factor for Gestational Diabetes?

Exposure to radon was linked to an increased risk for gestational diabetes, a population-based cohort study suggested. Among 9,107 mothers-to-be, those living in U.S. counties

January 11, 2025

Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently

Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) — including liver cancer, cirrhosis, heart disease, and more — affect men and women differently,

December 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.